Cargando…

The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?

Bax and Bak, two functionally similar, pro-apoptotic proteins of the Bcl-2 family, are known as the gateway to apoptosis because of their requisite roles as effectors of mitochondrial outer membrane permeabilization (MOMP), a major step during mitochondria-dependent apoptosis. The mechanism of how c...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xu, O'Neill, Katelyn L., Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411521/
https://www.ncbi.nlm.nih.gov/pubmed/32802314
http://dx.doi.org/10.12688/f1000research.25607.1
_version_ 1783568398206107648
author Luo, Xu
O'Neill, Katelyn L.
Huang, Kai
author_facet Luo, Xu
O'Neill, Katelyn L.
Huang, Kai
author_sort Luo, Xu
collection PubMed
description Bax and Bak, two functionally similar, pro-apoptotic proteins of the Bcl-2 family, are known as the gateway to apoptosis because of their requisite roles as effectors of mitochondrial outer membrane permeabilization (MOMP), a major step during mitochondria-dependent apoptosis. The mechanism of how cells turn Bax/Bak from inert molecules into fully active and lethal effectors had long been the focal point of a major debate centered around two competing, but not mutually exclusive, models: direct activation and indirect activation. After intensive research efforts for over two decades, it is now widely accepted that to initiate apoptosis, some of the BH3-only proteins, a subclass of the Bcl-2 family, directly engage Bax/Bak to trigger their conformational transformation and activation. However, a series of recent discoveries, using previously unavailable CRISPR-engineered cell systems, challenge the basic premise that undergirds the consensus and provide evidence for a novel and surprisingly simple model of Bax/Bak activation: the membrane (lipids)-mediated spontaneous model. This review will discuss the evidence, rationale, significance, and implications of this new model.
format Online
Article
Text
id pubmed-7411521
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-74115212020-08-13 The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? Luo, Xu O'Neill, Katelyn L. Huang, Kai F1000Res Review Bax and Bak, two functionally similar, pro-apoptotic proteins of the Bcl-2 family, are known as the gateway to apoptosis because of their requisite roles as effectors of mitochondrial outer membrane permeabilization (MOMP), a major step during mitochondria-dependent apoptosis. The mechanism of how cells turn Bax/Bak from inert molecules into fully active and lethal effectors had long been the focal point of a major debate centered around two competing, but not mutually exclusive, models: direct activation and indirect activation. After intensive research efforts for over two decades, it is now widely accepted that to initiate apoptosis, some of the BH3-only proteins, a subclass of the Bcl-2 family, directly engage Bax/Bak to trigger their conformational transformation and activation. However, a series of recent discoveries, using previously unavailable CRISPR-engineered cell systems, challenge the basic premise that undergirds the consensus and provide evidence for a novel and surprisingly simple model of Bax/Bak activation: the membrane (lipids)-mediated spontaneous model. This review will discuss the evidence, rationale, significance, and implications of this new model. F1000 Research Limited 2020-08-06 /pmc/articles/PMC7411521/ /pubmed/32802314 http://dx.doi.org/10.12688/f1000research.25607.1 Text en Copyright: © 2020 Luo X et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Luo, Xu
O'Neill, Katelyn L.
Huang, Kai
The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?
title The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?
title_full The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?
title_fullStr The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?
title_full_unstemmed The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?
title_short The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?
title_sort third model of bax/bak activation: a bcl-2 family feud finally resolved?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411521/
https://www.ncbi.nlm.nih.gov/pubmed/32802314
http://dx.doi.org/10.12688/f1000research.25607.1
work_keys_str_mv AT luoxu thethirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved
AT oneillkatelynl thethirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved
AT huangkai thethirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved
AT luoxu thirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved
AT oneillkatelynl thirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved
AT huangkai thirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved